Position in ARVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,977,115
-$820,409 QoQ
Shares Held
358,257
0.0% QoQ
Ownership
0.548%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#33
of 198 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Derivatives in ARVN
reported options exposure · as of Dec 31, 2022CallValue
$3,421,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. ARVN ranks #50 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
328,635 | $43,793,900 | |
| 2 | KOD |
Kodiak Sciences Inc.
|
1,059,730 | $41,287,080 | |
| 3 | ALMS |
Alumis Inc.
|
870,548 | $24,497,220 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
72,842 | $24,386,773 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
388,682 | $22,594,084 | |
| 6 | CLDX |
Celldex Therapeutics, Inc.
|
478,500 | $17,804,985 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
504,559 | $15,555,553 | |
| 8 | RLMD |
Relmada Therapeutics, Inc.
|
2,148,359 | $14,866,644 |
All Filings in ARVN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,977,115 | 358,257 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,797,524 | 358,257 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,248,928 | 358,257 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $1,927,709 | 226,257 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,256,000 | 850,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,613,898 | 229,900 | Shares | Sole | 2025-05-15 | |
| 2022-12-31 | $3,421,000 | 100,000 | Call | Sole | 2023-02-14 | |
| 2022-09-30 | $4,449,000 | 100,000 | Call | Sole | 2022-11-14 | |
| 2021-03-31 | $557,223 | 8,430 | Shares | Sole | 2021-08-18 | |
| 2020-12-31 | $19,763,211 | 232,700 | Call | Sole | 2021-02-12 | |
| 2020-12-31 | $8,493,000 | 100,000 | Put | Sole | 2021-02-12 | |
| 2020-12-31 | $358,064 | 4,216 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,770,517 | 159,700 | Call | Sole | 2020-11-16 | |
| 2020-06-30 | $3,558,594 | 106,100 | Call | Sole | 2020-08-14 | |
| 2020-06-30 | $5,165,160 | 154,000 | Put | Sole | 2020-08-14 | |
| 2020-03-31 | $2,260,830 | 56,100 | Call | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||